Indian hospital chains are embracing the power of artificial intelligence (AI) and generative AI (GenAI) to revolutionize the healthcare industry. Major players like Apollo Hospitals, Manipal Healthcare, and Aster DM Healthcare are leading the charge by incorporating AI into various aspects of patient care.
Apollo Hospitals, for instance, is not only using AI for prediction, prevention, diagnosis, and personalized management but also sharing its AI technology with smaller hospitals through regional hubs. This innovative approach allows for real-time patient monitoring and early detection of declines in patient condition.
Madhu Sasidhar, president and CEO of Apollo’s hospital division, highlighted the benefits of AI technology in monitoring every patient and making it available to other hospitals. Apollo is investing heavily in AI/machine learning to set new medical benchmarks, with tools like AI CVD for predicting cardiovascular disease risk and AI-enabled platforms for diagnostics and patient care.
Similarly, Manipal Healthcare is utilizing conversational AI to interact with patients and families, as well as for early alerts on patients who may require intensive care. Dilip Jose, managing director of Manipal Healthcare, emphasized the importance of carefully selecting AI applications and use cases to ensure optimal outcomes.
Aster DM Healthcare has taken a step further by establishing an AI Lab in collaboration with the Indian Institute of Science. The AI Lab has developed AI Carpal Tunnel Syndrome (CTS), a groundbreaking technology that revolutionizes nerve ultrasound diagnostics with 95% accuracy. Nitish Shetty, CEO of Aster DM Healthcare, highlighted the commitment to ethical AI practices and data privacy in their pursuit of healthcare excellence.
Overall, the integration of AI in Indian hospital chains is paving the way for a new era of healthcare excellence, combining human expertise with cutting-edge technology to improve patient outcomes and efficiency in diagnosis and treatment.